Laser Closure of Anal Fistula (FiLaC)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04161469 |
Recruitment Status : Unknown
Verified November 2019 by Kursat Serin, Surp Pırgiç Armenian Hospital.
Recruitment status was: Recruiting
First Posted : November 13, 2019
Last Update Posted : November 13, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Anal Fistula Fistula in Ano Sphincter Ani Incontinence | Procedure: Laser closure of the anal fistula tract (FiLaC) Procedure: Internal orifice closure | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 80 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Intervention Model Description: | The FiLaC procedure was performed using a ceramic diode laser platform (12 watts, 1470-nm wavelength). The laser fiber was introduced into the fistula tract via the external orifice using the seldinger maneuver until the internal orifice was found. The fiber delivered laser energy homogenously at 3600, causing shrinkage of the fistula tract around the fiber while it was withdrawn at the speed of 1 mm/s (2). We planned to randomized patients in two groups. Group 1) FiLaC closure of the tract, group 2) FiLaC closure of the tract with an additional surgical technique as the closure of the internal orifice with a purse-string suture using 2-0 polyglactin (VicrylR). |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Laser Closure of Anal Fistula (FiLaC); Do we Need to Close Internal Orifice? |
Actual Study Start Date : | August 1, 2019 |
Estimated Primary Completion Date : | October 1, 2020 |
Estimated Study Completion Date : | October 1, 2020 |
Arm | Intervention/treatment |
---|---|
Group 1
Patients diagnosed with anal fistula treated by laser closure of the tract
|
Procedure: Laser closure of the anal fistula tract (FiLaC)
The FiLaC procedure was performed using a ceramic diode laser platform (12 watts, 1470-nm wavelength). The laser fiber was introduced into the fistula tract via the external orifice using the seldinger maneuver until the internal orifice was found. The fiber delivered laser energy homogenously at 3600, causing shrinkage of the fistula tract around the fiber while it was withdrawn at the speed of 1 mm/s |
Group 2
Patients diagnosed with anal fistula treated by laser closure of the tract with an additional surgical technique as the closure of the internal orifice with a purse-string suture using 2-0 polyglactin
|
Procedure: Laser closure of the anal fistula tract (FiLaC)
The FiLaC procedure was performed using a ceramic diode laser platform (12 watts, 1470-nm wavelength). The laser fiber was introduced into the fistula tract via the external orifice using the seldinger maneuver until the internal orifice was found. The fiber delivered laser energy homogenously at 3600, causing shrinkage of the fistula tract around the fiber while it was withdrawn at the speed of 1 mm/s Procedure: Internal orifice closure Closure of internal orifice with a purse-string suture using 2-0 polyglactin suture material. |
- Change from perianal fistula disease severity score at 6 months [ Time Frame: 6th month after the surgery ]
0: no active disease or complete healing,
- slight drainage with minimal symptoms,
- persistent symptomatic drainage,
- painful symptomatic drainage,
- severe perianal disease potentially requiring diversion

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- complex anal fistula
- high anal fistulas
- recurrent anal fistulas
Exclusion Criteria:
- superficial anal fistulas
- multibranching anal fistulas

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04161469
Contact: Kursat Serin, Ass. Prof. | 00905322008163 | dr_krserin@hotmail.com | |
Contact: Cem Terzi, Prof. | 00905323776935 | mustafcem@gmail.com |
Turkey | |
Surp Pırgic AH | Recruiting |
Istanbul, Zeytinburnu, Turkey | |
Contact: Kursat R Serin, Ass. Prof. 00905322008163 dr_krserin@hotmail.com | |
Contact: Cem Terzi, Prof. 00905323776935 mustafcem@gmail.com |
Responsible Party: | Kursat Serin, Asistant Profesor, Surp Pırgiç Armenian Hospital |
ClinicalTrials.gov Identifier: | NCT04161469 |
Other Study ID Numbers: |
2019-10 |
First Posted: | November 13, 2019 Key Record Dates |
Last Update Posted: | November 13, 2019 |
Last Verified: | November 2019 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Plan Description: | Study Protocol Statistical Analysis Plan (SAP) Informed Consent Form (ICF) Clinical Study Report (CSR) |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
sphincter injury anal abscess incontinence |
Rectal Fistula Fistula Pathological Conditions, Anatomical Intestinal Fistula Digestive System Fistula |
Digestive System Diseases Intestinal Diseases Gastrointestinal Diseases Rectal Diseases |